Vycor Medical (VYCO) Income from Continuing Operations (2010 - 2026)
Vycor Medical's (VYCO) quarterly Income from Continuing Operations came in at -$19109.0 in Q2 2026, down 174.32% year-over-year from $25713.0 in Q2 2025, and down 195.09% quarter-over-quarter from $20095.0 in Q1 2026.
Powered by 
Analysis
Vycor Medical (VYCO) Income from Continuing Operations (2010 - 2026) Analysis & Trends
Vycor Medical (VYCO) has reported Income from Continuing Operations for 17 consecutive years, with -$19109.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Income from Continuing Operations fell 174.32% year-over-year to -$19109.0 in Q2 2026; TTM through Jun 2026 was -$56403.0, a 28.83% increase from a year earlier, with the FY2025 full-year figure at -$55450.0, up 34.37% from the prior year.
- Income from Continuing Operations was -$19109.0 for Q2 2026 at Vycor Medical, down from $20095.0 in the prior quarter.
- Over five years, Income from Continuing Operations peaked at $70791.0 in Q2 2023 and troughed at -$115870.0 in Q4 2022.
- A 5-year average of -$35496.7 and a median of -$34510.5 in 2024 frame the typical range for Income from Continuing Operations.
- Across the five-year window, Income from Continuing Operations tumbled 10463.31% in 2022 and jumped 357.41% in 2025, its largest moves.
- Over 5 years, Income from Continuing Operations stood at -$115870.0 in 2022, then grew by 22.36% to -$89961.0 in 2023, then jumped by 92.57% to -$6685.0 in 2024, then plunged by 833.12% to -$62379.0 in 2025, then soared by 69.37% to -$19109.0 in 2026.
- The last three Income from Continuing Operations figures came in at -$19109.0 (Q2 2026), $20095.0 (Q1 2026), and -$62379.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 823.20 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 1.48 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 1.28 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 905.00 Mn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 241.40 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -92.00 Mn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 249.10 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Vycor Medical | 2.34 Mn | 2.18 Mn | 344,445.00 | -19,109.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -19,109.00 |
| Mar 31, 2026 | 20,095.00 |
| Dec 31, 2025 | -62,379.00 |
| Sep 30, 2025 | 4,990.00 |
| Jun 30, 2025 | 25,713.00 |
| Mar 31, 2025 | -38,514.00 |
| Dec 31, 2024 | -6,685.00 |
| Sep 30, 2024 | -59,770.00 |
| Jun 30, 2024 | -9,989.00 |
| Mar 31, 2024 | -30,507.00 |
| Dec 31, 2023 | -89,961.00 |
| Sep 30, 2023 | -51,479.00 |
| Jun 30, 2023 | 70,791.00 |
| Mar 31, 2023 | 7,569.00 |
| Dec 31, 2022 | -115,870.00 |
| Sep 30, 2022 | -112,312.00 |
| Jun 30, 2022 | -97,726.00 |
| Mar 31, 2022 | -73,797.00 |
| Dec 31, 2021 | -186,104.00 |
| Sep 30, 2021 | 7,659.00 |